-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Monte Rosa Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2020 to Q2 2024.
- Monte Rosa Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $2.58M, a 15.7% increase year-over-year.
- Monte Rosa Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $9.49M, a 31.7% increase year-over-year.
- Monte Rosa Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $8.3M, a 114% increase from 2022.
- Monte Rosa Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $3.88M.
- Monte Rosa Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.08M, a 86.3% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)